Is 4153.TWO overvalued or undervalued?

4153.TWO currently has a P/E ratio of 19.07. Relative to the sector average of 26.70, this suggests the stock may be undervalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy DIVA Laboratories, Ltd. stock?

DIVA Laboratories, Ltd. trades on TWO. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of 4153.TWO?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 4153.TWO protect my money against local inflation?

Many investors in Latin America buy international stocks like 4153.TWO to protect their purchasing power. Because 4153.TWO is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 4153.TWO shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 4153.TWO a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 4153.TWO diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks4153.TWO

DIVA Laboratories, Ltd.

NT$30.90-NT$0.75-2.37%

TWO / TWD

Market cap

NT$1.8B

P/E

19.1

EPS (TTM)

NT$0.05

Dividend yield

6.47%

Beta

0.20

1Y return

-18.90%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$26M2021

$31M2022

$29M2023

$26M2024

$28M2025

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.00Low
Current ratio2.41
Cash ratio1.10
Net margin10.7%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

4153.TWO19.1
Healthcare sector median26.7
S&P 50022.0

Trades about 29% below its sector, cheaper than its peers on earnings.

Ratios

PEG2.90
Price to book1.89
EPS (TTM)NT$0.05
Payout ratio12,223%
FCF yield0.96%

Range & risk

NT$29.00NT$38.80

Trading in the lower third of its 52-week band

Beta0.20

Profile

What DIVA Laboratories, Ltd. actually does

DIVA Laboratories, Ltd. specializes in the global provision of advanced display technologies. Its comprehensive product lineup caters to critical environments, including specialized endo/surgical displays designed to render both static and dynamic imagery with precision for hybrid and integrated operating theaters, as well as crucial control room applications. Furthermore, DIVA offers a range of color and monochrome monitors tailored for high-accuracy radiology and broader medical imaging purposes. Beyond healthcare, the company develops interactive touch displays and human-machine interface (HMI) solutions, alongside robust medical and industrial enclosures. DIVA also serves original design manufacturers (ODMs) and original equipment manufacturers (OEMs) with custom display units, in addition to a broader portfolio of video solutions. Established in 1995, DIVA Laboratories, Ltd. maintains its corporate headquarters in New Taipei City, Taiwan.

CEO

Chen Gene

Employees

154

Headquarters

New Taipei City, TP

Founded

2012-07-17

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 4153.TWO and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

4153.TWO has a beta of 0.20, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

DIVA Laboratories, Ltd.